Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole in CARD9 S12N Crohn's Disease
NCT04966585Phase 4Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Aug 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of posaconazole in Crohn's disease, sponsored by Cedars-Sinai Medical Center. Started Aug 2022; status: terminated.
02
Drugs
posaconazole
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04966585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04966585.